Hugh Griffith
Founder at NUCANA PLC
Net worth: 328 907 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christopher Barry Wood | M | 78 |
MedAnnex Ltd.
 MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom.
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY.
EdixoMed Ltd.
 EdixoMed Ltd. BiotechnologyHealth Technology Part of Mativ Holdings, Inc., EdixoMed Ltd. engages in research and development of biotechnology. The private company is based in Edinburgh, UK. The British company was founded by Hugh Stephen Griffith. | 27 years |
| Isaac Cheng | M | 49 |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | 4 years |
| Kathryn Collins | F | - | 25 years | |
| Elliott Levy | M | 64 | 3 years | |
| Martin Mellish | M | 66 | 15 years | |
| Scott Leinenweber | M | - | 27 years | |
| Bali Muralidhar | M | 44 | 4 years | |
| Cyrille Leperlier | M | 70 | 6 years | |
| Philip Boudreau | M | 51 | 27 years | |
| Adam George | M | 54 | 6 years | |
| Andrew Kay | M | 69 | 4 years | |
| Elisabeth Oelmann | M | - | 4 years | |
| John-Paul Gallivan | M | - | - | |
| James Ingham | M | - |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | 11 years |
| Keith Lipman | M | 53 |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | - |
| Martin Alexander Quinn | M | - | 7 years | |
| Wilfred Sydney Hanna | M | 57 |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | - |
| Ian Abercrombie | M | - |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | 5 years |
| Donald Munoz | M | 56 | 9 years | |
| Andrea Wainer | F | - | 27 years | |
| Stuart Grant | M | - | 6 years | |
| Theresa Margaret Bruce | F | 60 | - | |
| Jeffrey Bloss | M | 68 | 3 years | |
| MaryJane Rafii | M | - |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | 18 years |
| Michelle Myers | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey Leiden | M | 68 | 6 years | |
| Fred B. Parks | M | 76 | 1 years | |
| Robert Parkinson | M | 73 | 25 years | |
| Roxanne Austin | F | 63 | 22 years | |
| Rafaèle Elisabeth Tordjman | M | 54 | - | |
| David A. L. Owen | M | 85 | - | |
| Brian Yoor | M | 54 | 23 years | |
| Kristen Williams | F | 50 |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | 3 years |
| John B. Thomas | M | - | 18 years | |
| Paul Clark | M | 76 | 14 years | |
| James Healy | M | 58 | 8 years | |
| Tom R. Hodgson | M | 82 | 27 years | |
| Roy S. Roberts | M | 84 | - | |
| Duane L. Burnham | M | 82 | 9 years | |
| Todd D. Bosse | M | - | 8 years | |
| Richard R. Copp | M | - | 10 years | |
| Bill Welch | M | 62 | 5 years | |
| Paul A. Arrendell | M | 58 | 6 years | |
| Patrick Taylor Horn | M | 69 | 5 years | |
| Anne Borgman | M | 56 | 7 years | |
| Jeffrey D. Alder | M | - | 8 years | |
| Joe R. Sanders | M | - | 10 years | |
| Robert G. Wilkins | M | 69 | - | |
| David Stamler | M | 63 | 4 years | |
| Jeff Smith | M | 64 | 5 years | |
| Preston T. Simons | M | - | 15 years | |
| Michael Zbinovec | M | - | 8 years | |
| Tina Flatau | M | - |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | - |
| William Henry Mullen | M | - | 3 years | |
| Paolo Augusto Paoletti | M | 73 | - | |
| Katarzyna Mazur-Hofsaess | M | 60 | 9 years | |
| Becky Mathews | F | - | 8 years | |
| Perry Nisen | M | 68 | 7 years | |
| Joseph M. Fortunak | M | 69 | 4 years | |
| Nancy Avila | F | 57 | 22 years | |
| Stan Bukofzer | M | 67 | 9 years | |
| Jennifer Mound Smoter | F | - | 14 years | |
| Louise Dube | M | - | 14 years | |
| Helen Giza | F | 56 | 5 years | |
| Michael DiTullio | M | 56 | 4 years | |
| Tejal Vakharia | M | 51 | 10 years | |
| Eugene Sun | M | 65 | 12 years | |
| Mark McCamish | M | 72 | 7 years | |
| Hank Plain | M | 66 | - | |
| Christopher A. Bleck | M | 66 | 18 years | |
| David Milligan | M | 83 | 17 years | |
| Joseph M. Nemmers | M | 69 | - | |
| Jay B. Johnston | M | 77 | 24 years | |
| Robert J. Koska | M | 66 | - | |
| Timothy Walbert | M | 57 | 4 years | |
| Luke Seikkula | M | 60 | 10 years | |
| Joseph G. Darling | M | 66 | 7 years | |
| Robert Walder | M | 71 | 6 years | |
| Joy Amundson | F | 69 | 16 years | |
| Kendall B. Hendrick | M | - | 8 years | |
| James Tyree | M | 71 | 12 years | |
| Joseph Cooper | M | 66 |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | 1 years |
| Alan S. Rosenthal | M | - | 6 years | |
| Bruce Jackson | M | - | 6 years | |
| Michael Williams | M | - | 11 years | |
| James Scibetta | M | 59 |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | 1 years |
| Bruce G. McCarthy | M | - | 7 years | |
| Terri Sebree | F | 66 | 8 years | |
| Eric Adams | M | 61 | 4 years | |
| Risa Stack | M | 55 | - | |
| Todd Davis | M | 63 | 5 years | |
| Andrew Saunders | M | - |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | 2 years |
| Yat Sun Or | M | 72 | 14 years | |
| Walter M. Narajowski | M | 71 | 23 years | |
| Jaime Contreras | F | 67 | 12 years | |
| Gary P. Coughlan | M | 80 | 11 years | |
| Douglas Liu | M | 62 | 10 years | |
| Jacob John Plattner | M | 77 | 21 years | |
| Kenneth Kashkin | M | 73 | 5 years | |
| Jacques Mulder | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 77 | 77.00% |
| United Kingdom | 24 | 24.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Hugh Griffith
- Personal Network